Biondo Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-105,815
Closed -$8.83M 85
2017
Q1
$8.83M Buy
+105,815
New +$7.44M 3.15% 8
2016
Q3
Sell
-106,027
Closed -$8.85M 79
2016
Q2
$8.85M Sell
106,027
-7,490
-7% -$665K 3.16% 8
2016
Q1
$10.4M Sell
113,517
-27,075
-19% -$2.44M 3.95% 7
2015
Q4
$14.2M Sell
140,592
-31,611
-18% -$3.29M 4.72% 6
2015
Q3
$16.9M Sell
172,203
-2,653
-2% -$295K 5.62% 4
2015
Q2
$20.5M Buy
174,856
+6,776
+4% +$740K 6.14% 3
2015
Q1
$16.5M Sell
168,080
-6,560
-4% -$666K 4.89% 7
2014
Q4
$16.5M Sell
174,640
-4,545
-3% -$470K 4.95% 7
2014
Q3
$19.1M Buy
179,185
+6,737
+4% +$660K 5.86% 3
2014
Q2
$14.3M Buy
172,448
+825
+0.5% +$64.2K 4.51% 6
2014
Q1
$12.2M Buy
171,623
+3,855
+2% +$302K 4.03% 8
2013
Q4
$12.6M Buy
167,768
+37,118
+28% +$2.58M 4.3% 7
2013
Q3
$8.21M Buy
130,650
+31,255
+31% +$1.87M 3.12% 10
2013
Q2
$5.1M Buy
+99,395
New +$5.18M 2.21% 13

Other funds holding GILD

Biondo Investment Advisors's GILD Position: Q2 2017 in Review

Biondo Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 105,815 shares — an estimated $8.83M sold.

Biondo Investment Advisors first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $20.5M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Biondo Investment Advisors reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Biondo Investment Advisors sold 105,815 Gilead Sciences shares in Q2 2017, an estimated $8.83M.
  • Biondo Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Biondo Investment Advisors's Gilead Sciences position peaked at $20.5M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Biondo Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.